SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Charles River Laboratories International, Inc. – ‘10-Q’ for 3/28/20 – ‘EX-31.2’

On:  Thursday, 5/7/20, at 3:02pm ET   ·   For:  3/28/20   ·   Accession #:  1100682-20-12   ·   File #:  1-15943

Previous ‘10-Q’:  ‘10-Q’ on 11/6/19 for 9/28/19   ·   Next:  ‘10-Q’ on 8/5/20 for 6/27/20   ·   Latest:  ‘10-Q’ on 5/9/24 for 3/30/24   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/07/20  Charles River Labs Int’l, Inc.    10-Q        3/28/20   98:11M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.17M 
 2: EX-10.1     Material Contract                                   HTML    120K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     35K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     35K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     32K 
86: R1          Cover Page                                          HTML     82K 
53: R2          Condensed Consolidated Statements of Income         HTML     96K 
                (Unaudited)                                                      
22: R3          Condensed Consolidated Statements of Comprehensive  HTML     58K 
                Income (Unaudited)                                               
73: R4          Condensed Consolidated Balance Sheets (Unaudited)   HTML    146K 
83: R5          Condensed Consolidated Balance Sheets (Unaudited)   HTML     50K 
                (Parenthetical)                                                  
50: R6          Condensed Consolidated Statements of Cash Flows     HTML    113K 
                (Unaudited)                                                      
19: R7          Condensed Consolidated Statements of Changes in     HTML     76K 
                Equity (Unaudited)                                               
76: R8          Basis of Presentation                               HTML     53K 
82: R9          Business Acquisitions                               HTML    113K 
58: R10         Revenue From Contracts With Customers               HTML    110K 
90: R11         Segment Information                                 HTML    135K 
34: R12         Supplemental Balance Sheet Information              HTML    101K 
23: R13         Venture Capital and Other Investments               HTML     33K 
59: R14         Fair Value                                          HTML    122K 
91: R15         Goodwill and Intangible Assets                      HTML     93K 
35: R16         Long-Term Debt and Finance Lease Obligations        HTML     69K 
24: R17         Equity and Noncontrolling Interests                 HTML     92K 
57: R18         Income Taxes                                        HTML     34K 
92: R19         Pension and Other Post-Retirement Benefit Plans     HTML     48K 
51: R20         Stock-Based Compensation                            HTML     44K 
20: R21         Foreign Currency Contracts                          HTML     64K 
74: R22         Restructuring and Asset Impairments                 HTML     82K 
84: R23         Leases                                              HTML    201K 
52: R24         Commitments and Contingencies                       HTML     31K 
21: R25         Basis of Presentation (Policies)                    HTML     64K 
75: R26         Business Acquisitions (Tables)                      HTML     90K 
85: R27         Revenue From Contracts With Customers (Tables)      HTML    127K 
54: R28         Segment Information (Tables)                        HTML    176K 
18: R29         Supplemental Balance Sheet Information (Tables)     HTML    112K 
26: R30         Fair Value (Tables)                                 HTML    114K 
38: R31         Goodwill and Intangible Assets (Tables)             HTML     95K 
89: R32         Long-Term Debt and Finance Lease Obligations        HTML     55K 
                (Tables)                                                         
56: R33         Equity and Noncontrolling Interests (Tables)        HTML     88K 
25: R34         Pension and Other Post-Retirement Benefit Plans     HTML     47K 
                (Tables)                                                         
37: R35         Stock-Based Compensation (Tables)                   HTML     45K 
88: R36         Foreign Currency Contracts (Tables)                 HTML     64K 
55: R37         Restructuring and Asset Impairments (Tables)        HTML     85K 
27: R38         Leases (Tables)                                     HTML    138K 
36: R39         Basis of Presentation (Details)                     HTML     29K 
12: R40         BUSINESS ACQUISITIONS - Narrative (Details)         HTML     78K 
47: R41         BUSINESS ACQUISITIONS - Purchase Price Allocation   HTML     81K 
                (Details)                                                        
81: R42         BUSINESS ACQUISITIONS - Definite-Lived Intangible   HTML     51K 
                Assets (Details)                                                 
72: R43         BUSINESS ACQUISITIONS - Pro Forma Information       HTML     37K 
                (Details)                                                        
11: R44         REVENUE FROM CONTRACTS WITH CUSTOMERS -             HTML     46K 
                Disaggregation of Revenues by Major Business Line                
                (Details)                                                        
46: R45         REVENUE FROM CONTRACTS WITH CUSTOMERS - Schedule    HTML     57K 
                of Estimated Revenue Related to Performance                      
                Obligations (Details)                                            
80: R46         REVENUE FROM CONTRACTS WITH CUSTOMERS - Narrative   HTML     38K 
                (Details)                                                        
71: R47         REVENUE FROM CONTRACTS WITH CUSTOMERS - Schedule    HTML     36K 
                of Client Receivables, Contract Assets and                       
                Contract Liabilities (Details)                                   
13: R48         SEGMENT INFORMATION - Narrative (Details)           HTML     29K 
45: R49         SEGMENT INFORMATION - Revenue and Other Financial   HTML     47K 
                Information by Reportable Segment (Details)                      
39: R50         SEGMENT INFORMATION - Reconciliation of Segment     HTML     41K 
                Operating Income, Depreciation and Amortization,                 
                and Capital Expenditures (Details)                               
29: R51         SEGMENT INFORMATION - Revenue Per Significant       HTML     37K 
                Product or Service (Details)                                     
65: R52         SEGMENT INFORMATION - Summary of Unallocated        HTML     48K 
                Corporate Overhead (Details)                                     
97: R53         SEGMENT INFORMATION - Disaggregation of Revenue by  HTML     42K 
                Geographic Area (Details)                                        
40: R54         Supplemental Balance Sheet Information (Details)    HTML    125K 
30: R55         VENTURE CAPITAL AND OTHER INVESTMENTS - Narrative   HTML     42K 
                (Details)                                                        
66: R56         FAIR VALUE - Fair Value of Assets and Liabilities   HTML     61K 
                (Details)                                                        
98: R57         FAIR VALUE - Contingent Consideration (Details)     HTML     40K 
41: R58         FAIR VALUE - Schedule of Fair Value of Debt         HTML     44K 
                (Details)                                                        
28: R59         GOODWILL AND INTANGIBLE ASSETS - Rollforward of     HTML     44K 
                Goodwill (Details)                                               
69: R60         GOODWILL AND INTANGIBLE ASSETS - Schedule of Other  HTML     52K 
                Intangible Assets (Details)                                      
77: R61         LONG-TERM DEBT AND FINANCE LEASE OBLIGATIONS -      HTML     61K 
                Schedule of Long-Term Debt (Details)                             
48: R62         LONG-TERM DEBT AND FINANCE LEASE OBLIGATIONS -      HTML    102K 
                Narrative (Details)                                              
14: R63         EQUITY AND NONCONTROLLING INTERESTS - Earnings Per  HTML     54K 
                Share (Details)                                                  
70: R64         EQUITY AND NONCONTROLLING INTERESTS - Narrative     HTML     58K 
                (Details)                                                        
78: R65         EQUITY AND NONCONTROLLING INTERESTS - Treasury      HTML     40K 
                Shares (Details)                                                 
49: R66         EQUITY AND NONCONTROLLING INTERESTS - Accumulated   HTML     54K 
                Other Comprehensive Income (Loss) (Details)                      
15: R67         EQUITY AND NONCONTROLLING INTERESTS - Rollforward   HTML     46K 
                of Redeemable Noncontrolling Interest (Details)                  
67: R68         Income Taxes (Details)                              HTML     45K 
79: R69         Pension and Other Post-Retirement Benefit Plans     HTML     50K 
                (Details)                                                        
96: R70         STOCK-BASED COMPENSATION - Stock Based              HTML     40K 
                Compensation Expense (Details)                                   
62: R71         FOREIGN CURRENCY CONTRACTS - Schedule of            HTML     42K 
                Derivative Instruments on Statements of Income                   
                (Details)                                                        
33: R72         FOREIGN CURRENCY CONTRACTS - Narrative (Details)    HTML     34K 
44: R73         FOREIGN CURRENCY CONTRACTS - Schedule of Notional   HTML     38K 
                and Fair Value of Foreign Currency Contracts                     
                (Details)                                                        
94: R74         RESTRUCTURING AND ASSET IMPAIRMENTS -               HTML     45K 
                Restructuring Costs by Classification on the                     
                Statements of Income (Details)                                   
60: R75         RESTRUCTURING AND ASSET IMPAIRMENTS -               HTML     39K 
                Restructuring Costs by Reportable Segment                        
                (Details)                                                        
31: R76         RESTRUCTURING AND ASSET IMPAIRMENTS - Narrative     HTML     38K 
                (Details)                                                        
42: R77         RESTRUCTURING AND ASSET IMPAIRMENTS - Rollforward   HTML     40K 
                of Severance and Transition Costs Liability                      
                (Details)                                                        
93: R78         LEASES - Right-of-Use Lease Assets and Lease        HTML     45K 
                Liabilities in Condensed Consolidated Financial                  
                Statements (Details)                                             
63: R79         LEASES - Components of Operating and Finance Lease  HTML     46K 
                Costs (Details)                                                  
95: R80         LEASES - Supplemental Cash Flow Information         HTML     43K 
                (Details)                                                        
61: R81         LEASES - Weighted Average Remaining Lease Term and  HTML     40K 
                Discount Rates (Details)                                         
32: R82         LEASES - Schedule of Future Minimum Lease Payments  HTML     69K 
                (Details)                                                        
43: R83         LEASES - Narrative (Details)                        HTML     35K 
68: XML         IDEA XML File -- Filing Summary                      XML    181K 
16: XML         XBRL Instance -- crl-20200328_htm                    XML   3.07M 
17: EXCEL       IDEA Workbook of Financial Reports                  XLSX    100K 
 7: EX-101.CAL  XBRL Calculations -- crl-20200328_cal                XML    334K 
 8: EX-101.DEF  XBRL Definitions -- crl-20200328_def                 XML    767K 
 9: EX-101.LAB  XBRL Labels -- crl-20200328_lab                      XML   1.81M 
10: EX-101.PRE  XBRL Presentations -- crl-20200328_pre               XML   1.14M 
 6: EX-101.SCH  XBRL Schema -- crl-20200328                          XSD    182K 
64: JSON        XBRL Instance as JSON Data -- MetaLinks              413±   617K 
87: ZIP         XBRL Zipped Folder -- 0001100682-20-000012-xbrl      Zip    396K 


‘EX-31.2’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

Exhibit 31.2
CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
AND RULE 13a-14(a)/15d-14(a) OF THE EXCHANGE ACT OF 1934
I, David R. Smith, Corporate Executive Vice President and Chief Financial Officer of Charles River Laboratories International, Inc. (the registrant) certify that:
1. I have reviewed this quarterly report on Form 10-Q for the quarter ended March 28, 2020 of the registrant;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a. designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b. designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c. evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and
d. disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

May 7, 2020
Corporate Executive Vice President and Chief Financial Officer
Charles River Laboratories International, Inc.



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:5/7/204,  8-K
For Period end:3/28/20
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/22/23  Charles River Labs Int’l, Inc.    10-K       12/31/22  119:17M
 2/16/22  Charles River Labs Int’l, Inc.    10-K       12/25/21  135:18M
 2/17/21  Charles River Labs Int’l, Inc.    10-K       12/26/20  138:18M
Top
Filing Submission 0001100682-20-000012   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 12:11:35.1am ET